Balance between activating NKG2D, DNAM‐1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts
Balance between activating NKG2D, DNAM‐1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts
SummaryRheumatoid arthritis (RA) is an autoimmune disease characterized by chronic inflammation and synovial hyperplasia leading to progressive joint destruction. Fibroblast‐like synoviocytes (FLS) are central components of the aggressive, tumour‐like synovial structure termed pannus, which invades the joint space and cartilage. A distinct natural killer (NK) cell subset expressing the inhibitory CD94/NKG2A receptor is present in RA synovial fluid. Little is known about possible cellular interactions between RA‐FLS and NK cells. We used cultured RA‐FLS and the human NK cell line Nishi, of which the latter expresses an NK receptor repertoire similar to that of NK cells in RA synovial fluid, as an in vitro model system of RA‐FLS/NK cell cross‐talk. We show that RA‐FLS express numerous ligands for both activating and inhibitory NK cell receptors, and stimulate degranulation of Nishi cells. We found that NKG2D, DNAM‐1, NKp46 and NKp44 are the key activating receptors involved in Nishi cell degranulation towards RA‐FLS. Moreover, blockade of the interaction between CD94/NKG2A and its ligand HLA‐E expressed on RA‐FLS further enhanced Nishi cell degranulation in co‐culture with RA‐FLS. Using cultured RA‐FLS and the human NK cell line Nishi as an in vitro model system of RA‐FLS/NK cell cross‐talk, our results suggest that cell‐mediated cytotoxicity of RA‐FLS may be one mechanism by which NK cells influence local joint inflammation in RA.
- University of Copenhagen Denmark
- University of Copenhagen Denmark
- University of Oxford United Kingdom
- Karolinska University Hospital Sweden
- Copenhagen University Hospital Denmark
Antigens, Differentiation, T-Lymphocyte, Male, Cell Degranulation, Cell Line, Arthritis, Rheumatoid, Rheumatoid, Killer Cells, Humans, Antigens, Natural Cytotoxicity Triggering Receptor 2, T Lineage-Specific Activation Antigen 1, Natural Cytotoxicity Triggering Receptor 1, Arthritis, Histocompatibility Antigens Class I, Synovial Membrane, Fibroblasts, Up-Regulation, Killer Cells, Natural, T-Lymphocyte, NK Cell Lectin-Like Receptor Subfamily K, Differentiation, Natural, Female, NK Cell Lectin-Like Receptor Subfamily C, NK Cell Lectin-Like Receptor Subfamily D, HLA-E Antigens
Antigens, Differentiation, T-Lymphocyte, Male, Cell Degranulation, Cell Line, Arthritis, Rheumatoid, Rheumatoid, Killer Cells, Humans, Antigens, Natural Cytotoxicity Triggering Receptor 2, T Lineage-Specific Activation Antigen 1, Natural Cytotoxicity Triggering Receptor 1, Arthritis, Histocompatibility Antigens Class I, Synovial Membrane, Fibroblasts, Up-Regulation, Killer Cells, Natural, T-Lymphocyte, NK Cell Lectin-Like Receptor Subfamily K, Differentiation, Natural, Female, NK Cell Lectin-Like Receptor Subfamily C, NK Cell Lectin-Like Receptor Subfamily D, HLA-E Antigens
17 Research products, page 1 of 2
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
- 2017IsRelatedTo
chevron_left - 1
- 2
chevron_right
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).42 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
